Schedule 13G ownership disclosure
ZAI LAB LTD
Ordinary shares, par value US $0.000006 per share · CUSIP: 98887Q104
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Qiming Corporate GP IV, Ltd.
Shares: 48,883,643.00 · Class: 4.4%
- Qiming Managing Directors Fund IV, L.P.
Shares: 1,496,235.00 · Class: 0.1%
- Qiming GP IV, L.P.
Shares: 47,387,408.00 · Class: 4.2%
- Qiming Venture Partners IV, L.P.
Shares: 47,387,408.00 · Class: 4.2%
- QM11 Limited
Shares: 48,883,643.00 · Class: 4.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001839126-26-000003
- Form type
- SCHEDULE 13G/A
- Filer
- Qiming Corporate GP IV, Ltd
- CIK
- CIK 1839126
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership